- Home
- KALV vs MERC Comparison
KALV vs MERC Comparison
Compare KALV & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- MERC
- Stock Information
- Founded
- KALV N/A
- MERC 1968
- Country
- KALV United States
- MERC Canada
- Employees
- KALV N/A
- MERC N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- MERC Paper
- Sector
- KALV Health Care
- MERC Basic Materials
- Exchange
- KALV Nasdaq
- MERC Nasdaq
- Market Cap
- KALV 563.1M
- MERC 468.8M
- IPO Year
- KALV N/A
- MERC 1987
- Fundamental
- Price
- KALV $11.45
- MERC $6.15
- Analyst Decision
- KALV Strong Buy
- MERC Hold
- Analyst Count
- KALV 8
- MERC 2
- Target Price
- KALV $24.83
- MERC $7.75
- AVG Volume (30 Days)
- KALV 567.9K
- MERC 338.0K
- Earning Date
- KALV 03-12-2025
- MERC 05-08-2025
- Dividend Yield
- KALV N/A
- MERC 4.87%
- EPS Growth
- KALV N/A
- MERC N/A
- EPS
- KALV N/A
- MERC N/A
- Revenue
- KALV N/A
- MERC $2,043,360,000.00
- Revenue This Year
- KALV N/A
- MERC $3.26
- Revenue Next Year
- KALV N/A
- MERC $5.78
- P/E Ratio
- KALV N/A
- MERC N/A
- Revenue Growth
- KALV N/A
- MERC 2.48
- 52 Week Low
- KALV $7.30
- MERC $5.33
- 52 Week High
- KALV $15.50
- MERC $11.20
- Technical
- Relative Strength Index (RSI)
- KALV 47.44
- MERC 38.81
- Support Level
- KALV $11.83
- MERC $6.45
- Resistance Level
- KALV $12.50
- MERC $6.78
- Average True Range (ATR)
- KALV 0.58
- MERC 0.24
- MACD
- KALV -0.16
- MERC -0.05
- Stochastic Oscillator
- KALV 19.46
- MERC 27.17
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.